GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 201 filers reported holding GENMAB A/S in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $485 | -1.8% | 13,756 | +5.8% | 0.00% | 0.0% |
Q2 2023 | $494 | +25.7% | 12,997 | +25.0% | 0.00% | 0.0% |
Q1 2023 | $393 | +23.2% | 10,399 | +38.1% | 0.00% | +50.0% |
Q4 2022 | $319 | -99.9% | 7,532 | -16.6% | 0.00% | 0.0% |
Q3 2022 | $290,000 | -16.4% | 9,032 | -15.4% | 0.00% | -33.3% |
Q2 2022 | $347,000 | -28.3% | 10,678 | -20.2% | 0.00% | 0.0% |
Q1 2022 | $484,000 | -27.0% | 13,375 | -20.2% | 0.00% | -40.0% |
Q4 2021 | $663,000 | -19.4% | 16,769 | -16.8% | 0.01% | -28.6% |
Q2 2021 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $823,000 | 0.0% | 20,155 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $823,000 | – | 20,155 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 119,681 | $4,330,000 | 1.29% |
Hardman Johnston Global Advisors LLC | 982,087 | $35,532,000 | 1.14% |
Aquilo Capital Management, LLC | 167,500 | $6,060,000 | 0.89% |
TORRAY INVESTMENT PARTNERS LLC | 133,172 | $4,818,000 | 0.77% |
Lester Murray Antman dba SimplyRich | 50,044 | $1,810,000 | 0.63% |
First Light Asset Management, LLC | 161,913 | $5,858,000 | 0.52% |
Rokos Capital Management LLP | 28,565 | $10,531,000 | 0.49% |
Yorktown Management & Research Co Inc | 10,100 | $365,000 | 0.31% |
Quantamental Technologies LLC | 12,461 | $451,000 | 0.26% |
Campbell & CO Investment Adviser LLC | 24,972 | $903,000 | 0.24% |